Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis
Background: Understanding the effects of socioeconomic disparities in health outcomes is important to implement specific preventive actions. We assessed socioeconomic disparities in mortality indicators in a rural South African population over the period 2001–13. Methods: We used data from 21 villag...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X17302978 |
id |
doaj-237bfe84d1414547971557991f252647 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mr Chodziwadziwa W Kabudula, MSc Brian Houle, PhD Mark A Collinson, PhD Prof Kathleen Kahn, PhD Francesc Xavier Gómez-Olivé, PhD Prof Stephen Tollman, PhD Prof Samuel J Clark, PhD |
spellingShingle |
Mr Chodziwadziwa W Kabudula, MSc Brian Houle, PhD Mark A Collinson, PhD Prof Kathleen Kahn, PhD Francesc Xavier Gómez-Olivé, PhD Prof Stephen Tollman, PhD Prof Samuel J Clark, PhD Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis The Lancet Global Health |
author_facet |
Mr Chodziwadziwa W Kabudula, MSc Brian Houle, PhD Mark A Collinson, PhD Prof Kathleen Kahn, PhD Francesc Xavier Gómez-Olivé, PhD Prof Stephen Tollman, PhD Prof Samuel J Clark, PhD |
author_sort |
Mr Chodziwadziwa W Kabudula, MSc |
title |
Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis |
title_short |
Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis |
title_full |
Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis |
title_fullStr |
Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis |
title_full_unstemmed |
Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis |
title_sort |
socioeconomic differences in mortality in the antiretroviral therapy era in agincourt, rural south africa, 2001–13: a population surveillance analysis |
publisher |
Elsevier |
series |
The Lancet Global Health |
issn |
2214-109X |
publishDate |
2017-09-01 |
description |
Background: Understanding the effects of socioeconomic disparities in health outcomes is important to implement specific preventive actions. We assessed socioeconomic disparities in mortality indicators in a rural South African population over the period 2001–13.
Methods: We used data from 21 villages of the Agincourt Health and socio-Demographic Surveillance System (HDSS). We calculated the probabilities of death from birth to age 5 years and from age 15 to 60 years, life expectancy at birth, and cause-specific and age-specific mortality by sex (not in children <5 years), time period, and socioeconomic status (household wealth) quintile for HIV/AIDS and tuberculosis, other communicable diseases (excluding HIV/AIDS and tuberculosis) and maternal, perinatal, and nutritional causes, non-communicable diseases, and injury. We also quantified differences with relative risk ratios and relative and slope indices of inequality.
Findings: Between 2001 and 2013, 10 414 deaths were registered over 1 058 538 person-years of follow-up, meaning the overall crude mortality was 9·8 deaths per 1000 person-years. We found significant socioecomonic status gradients for mortality and life expectancy at birth, with outcomes improving with increasing socioeconomic status. An inverse relation was seen for HIV/AIDS and tuberculosis mortality and socioeconomic status that persisted from 2001 to 2013. Deaths from non-communicable diseases increased over time in both sexes, and injury was an important cause of death in men and boys. Neither of these causes of death, however, showed consistent significant associations with household socioeconomic status.
Interpretation: The poorest people in the population continue to bear a high burden of HIV/AIDS and tuberculosis mortality, despite free antiretroviral therapy being made available from public health facilities. Associations between socioeconomic status and increasing burden of mortality from non-communicable diseases is likely to become prominent. Integrated strategies are needed to improve access to and uptake of HIV testing, care, and treatment, and management of non-communicable diseases in the poorest populations.
Funding: Wellcome Trust, South African Medical Research Council, and University of the Witwatersrand, South Africa. |
url |
http://www.sciencedirect.com/science/article/pii/S2214109X17302978 |
work_keys_str_mv |
AT mrchodziwadziwawkabudulamsc socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis AT brianhoulephd socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis AT markacollinsonphd socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis AT profkathleenkahnphd socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis AT francescxaviergomezolivephd socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis AT profstephentollmanphd socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis AT profsamueljclarkphd socioeconomicdifferencesinmortalityintheantiretroviraltherapyerainagincourtruralsouthafrica200113apopulationsurveillanceanalysis |
_version_ |
1725096818921963520 |
spelling |
doaj-237bfe84d1414547971557991f2526472020-11-25T01:29:29ZengElsevierThe Lancet Global Health2214-109X2017-09-0159e924e93510.1016/S2214-109X(17)30297-8Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysisMr Chodziwadziwa W Kabudula, MSc0Brian Houle, PhD1Mark A Collinson, PhD2Prof Kathleen Kahn, PhD3Francesc Xavier Gómez-Olivé, PhD4Prof Stephen Tollman, PhD5Prof Samuel J Clark, PhD6MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaBackground: Understanding the effects of socioeconomic disparities in health outcomes is important to implement specific preventive actions. We assessed socioeconomic disparities in mortality indicators in a rural South African population over the period 2001–13. Methods: We used data from 21 villages of the Agincourt Health and socio-Demographic Surveillance System (HDSS). We calculated the probabilities of death from birth to age 5 years and from age 15 to 60 years, life expectancy at birth, and cause-specific and age-specific mortality by sex (not in children <5 years), time period, and socioeconomic status (household wealth) quintile for HIV/AIDS and tuberculosis, other communicable diseases (excluding HIV/AIDS and tuberculosis) and maternal, perinatal, and nutritional causes, non-communicable diseases, and injury. We also quantified differences with relative risk ratios and relative and slope indices of inequality. Findings: Between 2001 and 2013, 10 414 deaths were registered over 1 058 538 person-years of follow-up, meaning the overall crude mortality was 9·8 deaths per 1000 person-years. We found significant socioecomonic status gradients for mortality and life expectancy at birth, with outcomes improving with increasing socioeconomic status. An inverse relation was seen for HIV/AIDS and tuberculosis mortality and socioeconomic status that persisted from 2001 to 2013. Deaths from non-communicable diseases increased over time in both sexes, and injury was an important cause of death in men and boys. Neither of these causes of death, however, showed consistent significant associations with household socioeconomic status. Interpretation: The poorest people in the population continue to bear a high burden of HIV/AIDS and tuberculosis mortality, despite free antiretroviral therapy being made available from public health facilities. Associations between socioeconomic status and increasing burden of mortality from non-communicable diseases is likely to become prominent. Integrated strategies are needed to improve access to and uptake of HIV testing, care, and treatment, and management of non-communicable diseases in the poorest populations. Funding: Wellcome Trust, South African Medical Research Council, and University of the Witwatersrand, South Africa.http://www.sciencedirect.com/science/article/pii/S2214109X17302978 |